Lupin appoints Theresa Stevens to lead global M&As

Lupin Ltd, 3rd largest Indian pharmaceutical company by revenues, has appointed Theresa Stevens as Chief Corporate Development Officer for its global operations. Theresa will assume full responsibility for global merger and acquisitions and specialty business strategy.

Prior to joining Lupin, Theresa was with Aptalis pharma as the Chief Corporate Development Officer responsible for Mergers & Acquisitions (M&A), strategy and global business development. Theresa had also spent 9 years at Novartis, said the company statement.

Nilesh Gupta, Managing Director, Lupin Limited said, "I am sure her rich experience in the areas of M&A and Specialty Strategy within the Pharmaceutical and Biotech industry sector will help Lupin's growth plans."

On Monday, Lupin shares were closed at Rs 956.55, up by 0.14% on BSE.

Lupin had earlier appointed Maurice Chagnaud as President-Europe & Head of Inhalation Strategy. Chagnaud joined from Teva where he was the Vice President, Central & Eastern Europe.